Report Description
A recent market
intelligence report that is published by Data Insights Partner on Gene Therapy
market makes an offering of in-depth analysis of
segments and sub-segments in the regional and international Gene Therapy market. The research
also emphasizes on the impact of restraints, drivers, and macro indicators on
the regional and world Gene Therapy market over the short
as well as long period of time. A detailed presentation of forecast, trends,
and dollar values of international Gene Therapy market is offered. In accordance with the report, the global Gene
Therapy market is projected to expand at a CAGR of 30% over the period of forecast.
Market Insight, Drivers, Restraints&
Opportunity of the Market:
Gene therapy is a medical procedure which replaces
defective genes or introduces new genes n order to prevent or cure genetic
disorders. This procedure has become a bench mark in medical industry as there
is no requirement of surgery or drugs or other procedure which has side effects
on the individuals. Gene therapy was first commercialized in China in 2004 by
China based SiBono Gene Tech (product Gendicine).
The global gene therapy market has been expanding due to
the rigorous research conducted in the field of genetics. The rising awareness
about the capability of cure of several rare genetic diseases by gene therapy
is another important driver which leads the global gene therapy market during
the forecast period. Gene therapy has capability cure several life threatening
diseases such as cancer, cardiac diseases, AIDS, cystic fibrosis, age-related
disorders, sickle cell anemia etc. In March 2019, the director of the National
Health Institute (NIH), the U.S. announced that the recent clinical trials on
the gene therapy for the treatment of sickle cell anemia showed promising
result- therefore, increasing prevalence of aforementioned lie threatening
diseases would likely to drive the growth of the global gene therapy market
during the forecast period.
On the other hand, treatment cost and stringent
regulatory conditions etc. may hamper the growth of the global gene therapy
market in the upcoming future. The results of Gendicine clinical trials were
published in 2003 and the medicine got approval by the China State Food and
Drug Administration in the same year. Although approved in China, Gendicine’s
use is not very promising outside China. There are several concerns among the
researchers about the quality of the clinical trials performed and safety and
efficacy of the treatment. However, Gendicine’s equivalent Advexin (company
Introgen Therapueitcs) is still waiting for the FDA approval.
Increasing
investment to the gene therapy related research (around 10 Bn was invested in
2015 by private and public organizations), new product developments such as
(Zolgensma in 2019), strategic alliance among the key players (such as
collaboration between Axovant and Yposkesi) would bring the global gene therapy
market an opportunity to propel during the forecast period. In May 2019, Avexis
(a Novartis company) has got the FDA approval for Zolgensma for treatment of
spinal muscular atrophy for the pediatric patients (less than 2 years of age).
Segment Covered:
This market
intelligence report on the global gene therapy market encompasses market
segments based on product, application, target user and geography. On the basis
of product, the sub-markets is segmented into Yescarta, Kymriah, Strimvelis,
Gendicine, Zolgensma and others (Advexin). Based on application, the global
gene therapy market has been segregated into large B-Cell lymphoma, Car T Cell
therapy, ADA-SCID (adenosine deaminase deficiency), muscular atrophy, head and
neck squamus cell carcinoma, others (Crigler-Najjar syndrome). By target user,
the global gene therapy market is also classified into adult and pediatric. By
Geography, the global gene therapy market has been divided into North America
(the U.S., Canada), Latin America (Brazil, Mexico, Argentina and other
countries), Europe (Germany, France, the U.K., Spain, Italy, Russia, and other
countries), Asia Pacific (India, Japan, China, Australia and New Zealand and
other countries), Middle East and Africa (GCC, South Africa, Israel and Other
countries).
Profiling of Market
Players:
This business
intelligence report offers profiling of reputed companies that are operating in
the market. Companies such as Novartis, Gilead Sciences, Orchard Therapeutics
Ltd, SiBiono GeneTech Co, Introgen Therapeutics and among others have been
profiled into detail so as to offer a glimpse of the market leaders. Moreover,
parameters such as gene therapy market related investment & spending and
developments by major players of the market are tracked in this global report.
Report Highlights:
In-depth
analysis of the micro and macro indicators, market trends, and forecasts of
demand is offered by this business intelligence report. Furthermore, the report
offers a vivid picture of the factors that are steering and restraining the growth
of this market across all geographical segments. In addition to that, IGR-Growth
Matrix analysis is also provided in the report so as to share insight of the
investment areas that new or existing market players can take into consideration.
Various analytical tools such as DRO analysis, Porter's five forces analysis
has been used in this report to present a clear picture of the market. The
study focuses on the present market trends and provides market forecast from
the year 2017-2027. Emerging trends that would shape the market demand in the
years to come have been highlighted in this report. A competitive analysis in
each of the geographical segments gives an insight into market share of the
global players.
Salient Features:
Ø
This study offers
comprehensive yet detailed analysis of the Gene Therapy market, size of the
market (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the period of
forecast: 2019 – 2027, taking into account 2017 as the base year
Ø
It explains upcoming
revenue opportunities across various market segments and attractive matrix of
investment proposition for the said market
Ø
This market
intelligence report also offers pivotal insights about various market opportunities,
restraints, drivers, launch of new products, competitive market strategies of
leading market players, emerging market trends, and regional outlook
Ø
Profiling of
key market players in the world Gene Therapy market is done by
taking into account various parameters such as company strategies, distribution
strategies, product portfolio, financial performance, key developments,
geographical presence, and company overview
Ø
Leading
market players covered this report comprise names such as. Novartis, Gilead Sciences, Orchard Therapeutics Ltd, SiBiono
GeneTech Co, Introgen Therapeutics and among others
Ø
The data of
this report would allow management authorities and marketers of companies alike
to take informed decision when it comes to launch of products, government
initiatives, marketing tactics and expansion, and technical up gradation
Ø
The world
market for Gene Therapy market caters to the
needs of various stakeholders pertaining to this industry, namely suppliers, manufacturers,
investors, and distributors for Gene Therapy market. The research also caters to the rising needs of consulting
and research firms, financial analysts, and new market entrants
Ø
Research
methodologies that have been adopted for the purpose of this study have been
clearly elaborated so as to facilitate better understanding of the reports
Ø
Reports have
been made based on the guidelines as mandated by General Data Protection
Regulation
Ø
Ample number
of examples and case studies have been taken into consideration before coming
to a conclusion
Reasons to buy:
v
Identify
opportunities and plan strategies by having a strong understanding of the
investment opportunities in the Gene Therapy market
v
Identification
of key factors driving investment opportunities in the Gene Therapy market
v
Facilitate
decision-making based on strong historic and forecast data
v
Position
yourself to gain the maximum advantage of the industry’s growth potential
v
Develop
strategies based on the latest regulatory events
v
Identify key
partners and business development avenues
v
Respond to
your competitors’ business structure, strategy and prospects